Please assess the completion status of the following clinical trial:

Trial Title: A Study Comparing the Effect of Amorphous Calcium Carbonate (ACC) on Healing Time of Distal Radius Fractures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects with closed unilateral dorsally angulated fracture of the distal radius (Colles') visible by x-ray.~* Subjects that can begin taking the study treatment exactly 7 (+1) days from the fracture event.~* Subjects treated conservatively by closed reduction and immobilization~* Age 50-90 (inclusive)~* Subjects able to adhere to the visit schedule and protocol requirements and be available to complete the study.~* Subject that had signed the ICF.~Exclusion Criteria:~* Subjects with intra articular fracture or extra-articular fracture that meets the criteria for operative fracture fixation.~* Subjects with pins or plates in the wrist~* Sustained previous fractures or bone surgery in the currently fractured distal forearm~* Subjects with multiple trauma (several fractures at once)~* Subjects suffering from joint diseases that affect the function of the wrist and/or hand of the injured arm.~* Elevated serum calcium (\> 10.2 mg/dL)~* 25-hydroxyvitamin D \< 20 ng/mL~* Subjects suffering from active liver disease or clinical jaundice~* Subjects with current or a history of a malignant neoplasm in the 5 years prior to the study~* Cognitive impairment

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Amorphous calcium carbonate (Type: EXPERIMENTAL): 200 mg elemental calcium tablets, 2 in the morning and 2 in the evening, after a meal
- StarLac (Type: PLACEBO_COMPARATOR): Tablets containing 300 mg StarLac (starch cellulose and lactose blend) to be used as placebo, 2 tablets in the morning and 2 tablets in the evening, after a meal.

Based on this trial design, predict the completion outcome and termination type (if applicable).